1. Home
  2. TISI vs IBIO Comparison

TISI vs IBIO Comparison

Compare TISI & IBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Team Inc.

TISI

Team Inc.

HOLD

Current Price

$16.89

Market Cap

76.3M

ML Signal

HOLD

Logo iBio Inc.

IBIO

iBio Inc.

HOLD

Current Price

$1.62

Market Cap

84.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TISI
IBIO
Founded
1973
2008
Country
United States
United States
Employees
6800
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.3M
84.0M
IPO Year
1995
2009

Fundamental Metrics

Financial Performance
Metric
TISI
IBIO
Price
$16.89
$1.62
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$4.75
AVG Volume (30 Days)
9.9K
791.7K
Earning Date
05-12-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
73.08
EPS
N/A
N/A
Revenue
$896,483,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.19
N/A
52 Week Low
$12.34
$0.56
52 Week High
$20.01
$3.82

Technical Indicators

Market Signals
Indicator
TISI
IBIO
Relative Strength Index (RSI) 56.33 44.48
Support Level $13.12 $1.41
Resistance Level $18.61 $1.80
Average True Range (ATR) 0.91 0.13
MACD 0.02 -0.01
Stochastic Oscillator 44.92 25.41

Price Performance

Historical Comparison
TISI
IBIO

About TISI Team Inc.

Team Inc provides specialty industrial services, including inspection, engineering assessment, and mechanical repair and remediation required in maintaining high-temperature and high-pressure piping systems and vessels utilized in refining, petrochemicals, and others. The company operates in two segments, Inspection and Heat Treating and Mechanical Services. The Inspection and Heat Treating segment, which generates maximum revenue, provides conventional and non-destructive testing services for the process, pipeline, and power sectors, pipeline integrity management services, and field heat treating services, as well as associated engineering and condition assessment services. Geographically, the company derives its key revenue from the United States, followed by other countries, and Canada.

About IBIO iBio Inc.

iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.

Share on Social Networks: